about bpl

Bio Products Laboratory Ltd.


PRESS RELEASE - BPL's Supply of Factor X, XI and 8Y

London UK: Bio Products Laboratory (BPL) confirms to both the UK Department of Health and the Haemophilia Society that it has no intention to discontinue the manufacture and sales of Factor X (named patient), Factor XI (named patient) and 8Y (containing ADAMTS13).  BPL has assured ...

Date added: Friday 7th February 2014
Latest updated: Wednesday 8th February 2017

Patient information leaflets